Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $597.5000 (0.47%) ($589.0000 - $597.5000) on Wed. Jun. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 46 | Latest Price | $597.5000(0.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) DIA(38%) IWD(35%) SPLV(34%) SPY(34%) | Factors Impacting REGN price | REGN will decline at least -1.02% in a week (0% probabilities). VIXM(-10%) TBT(-9%) UUP(-6%) EDOC(-4%) VXX(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $602.89(-0.89%) | 10 Day Moving Average | $589.81(1.3%) | 20 Day Moving Average | $593.61(0.66%) | To recent high | -19.1% | To recent low | 9.1% | Market Cap | $63.352b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |